University of the West of Scotland Featured PhD Programmes
Imperial College London Featured PhD Programmes
University of the West of Scotland Featured PhD Programmes

Pharmacy / Pharmaceutics (health care) PhD Projects, Programs & Scholarships

We have 13 Pharmacy / Pharmaceutics (health care) PhD Projects, Programs & Scholarships

Discipline

Discipline

All disciplines

Location

Location

All locations

Institution

Institution

All Institutions

PhD Type

PhD Type

All PhD Types

Funding

Funding

All Funding


We have 13 Pharmacy / Pharmaceutics (health care) PhD Projects, Programs & Scholarships

Re-purposing diabetes medicines to manage bleeding complications in myeloproliferative neoplasms.

Myeloproliferative neoplasms (MPNs) are a group of three related blood cancers in which the bone marrow overproduces one of the three cellular components of blood (erythrocytes, leukocytes and platelets). Read more

Modulation of platelet-mediated innate immune responses in chronic lymphocytic leukaemia

Chronic lymphocytic leukaemia (CLL) is the most common form of leukaemia in the Western World. B-cell receptor-induced intracellular signals are critical for the survival of leukaemia cells and disruption of this pathway by the Bruton’s tyrosine kinase (Btk) inhibitor ibrutinib is a highly effective CLL therapy. Read more

Identification of novel glucose-dependent alterations responsible for platelet dysfunction in Type 2 diabetes.

Type 2 diabetes mellitus (T2DM) is a growing global healthcare problem. Clinical findings suggest that more than 70% of patients with T2DM will die of cardiovascular diseases (CVDs) including heart attack and stroke. Read more

How does the vascular matrix environment influence platelet activation?

The platelet is a blood cell that plays a key role in the prevention of bleeding. For platelets to form a clot or thrombus effectively, they must rearrange their actin cytoskeleton to withstand high shear stress from blood flow in the arteries. Read more

Biofilm disruption as an initial step in a novel strategy for treatment of chronic wounds based on multi-functional liposomal nanocarriers

  Research Group: Medicines Development and Pharmaceutical Sciences
The cost to the NHS of caring for patients with chronic wounds is conservatively estimated to be £4.5-5.7bn/year, or around 4% of the total expenditure on health. Read more
  • 1

Filtering Results